BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muneer A. Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations. Clin Psychopharmacol Neurosci 2020;18:507-26. [PMID: 33124585 DOI: 10.9758/cpn.2020.18.4.507] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheng D, Qin Z, Zheng Y, Xie J, Liang S, Zhang J, Feng Y, Zhang Z. Minocycline, a classic antibiotic, exerts psychotropic effects by normalizing microglial neuroinflammation-evoked tryptophan-kynurenine pathway dysregulation in chronically stressed male mice. Brain, Behavior, and Immunity 2023;107:305-318. [DOI: 10.1016/j.bbi.2022.10.022] [Reference Citation Analysis]
2 Polityńska B, Pokorska O, Wojtukiewicz AM, Sawicka M, Myśliwiec M, Honn KV, Tucker SC, Wojtukiewicz MZ. Is depression the missing link between inflammatory mediators and cancer? Pharmacology & Therapeutics 2022;240:108293. [DOI: 10.1016/j.pharmthera.2022.108293] [Reference Citation Analysis]
3 Tamimou R, Lumbroso S, Mouzat K, Lopez-castroman J. Genetic variations related to inflammation in suicidal ideation and behavior: A systematic review. Front Psychiatry 2022;13:1003034. [DOI: 10.3389/fpsyt.2022.1003034] [Reference Citation Analysis]
4 Fries GR, Saldana VA, Finnstein J, Rein T. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry 2022. [PMID: 36203007 DOI: 10.1038/s41380-022-01806-1] [Reference Citation Analysis]
5 Berber E, Sumbria D, Kokkaya S. A metabolic blueprint of COVID-19 and long-term vaccine efficacy. Drug Metabolism and Personalized Therapy 2022;0. [DOI: 10.1515/dmpt-2022-0148] [Reference Citation Analysis]
6 Puopolo T, Chang T, Liu C, Li H, Liu X, Wu X, Ma H, Seeram NP. Gram-Scale Preparation of Cannflavin A from Hemp (Cannabis sativa L.) and Its Inhibitory Effect on Tryptophan Catabolism Enzyme Kynurenine-3-Monooxygenase. Biology 2022;11:1416. [DOI: 10.3390/biology11101416] [Reference Citation Analysis]
7 Milosavljevic S, Smith AK, Wright CJ, Valafar H, Pocivavsek A. Kynurenine aminotransferase II inhibition promotes sleep and rescues impairments induced by neurodevelopmental insult.. [DOI: 10.1101/2022.09.20.508758] [Reference Citation Analysis]
8 Kilany A, Nashaat NH, Zeidan HM, Hashish AF, El-Saied MM, Abdelraouf ER. Kynurenine and oxidative stress in children having learning disorder with and without attention deficit hyperactivity disorder: possible role and involvement. BMC Neurol 2022;22:356. [PMID: 36127656 DOI: 10.1186/s12883-022-02886-w] [Reference Citation Analysis]
9 Davidson M, Rashidi N, Nurgali K, Apostolopoulos V. The Role of Tryptophan Metabolites in Neuropsychiatric Disorders. IJMS 2022;23:9968. [DOI: 10.3390/ijms23179968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Liaqat H, Parveen A, Kim SY. Neuroprotective Natural Products’ Regulatory Effects on Depression via Gut–Brain Axis Targeting Tryptophan. Nutrients 2022;14:3270. [DOI: 10.3390/nu14163270] [Reference Citation Analysis]
11 Chailurkit LO, Chanprasertyothin S, Thongmung N, Sritara P, Ongphiphadhanakul B. Targeted metabolomics suggests a probable role of the FTO gene in the kynurenine pathway in prediabetes. PeerJ 2022;10:e13612. [PMID: 35757166 DOI: 10.7717/peerj.13612] [Reference Citation Analysis]
12 Sun Y, Wang Z, Hou J, Shi J, Tang Z, Wang C, Zhao H. Shuangxinfang Prevents S100A9-Induced Macrophage/Microglial Inflammation to Improve Cardiac Function and Depression-Like Behavior in Rats After Acute Myocardial Infarction. Front Pharmacol 2022;13:832590. [DOI: 10.3389/fphar.2022.832590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lee JG, Woo YS, Park SW, Seog D, Seo MK, Bahk W. Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers. Clin Psychopharmacol Neurosci 2022;20:228-239. [DOI: 10.9758/cpn.2022.20.2.228] [Reference Citation Analysis]
14 Eryavuz Onmaz D, Tezcan D, Abusoglu S, Sivrikaya A, Kuzu M, Yerlikaya FH, Yilmaz S, Unlu A. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease. Amino Acids 2022. [PMID: 35604497 DOI: 10.1007/s00726-022-03170-4] [Reference Citation Analysis]
15 Dash S, Syed YA, Khan MR. Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Front Cell Dev Biol 2022;10:880544. [DOI: 10.3389/fcell.2022.880544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Verma K, Amitabh, Chandra M, Prasad DN, Debnath C, Mohanty H, Kohli E, Reddy MPK. Alteration in cerebral blood flow, kynurenines with respect to mood profile in freshly recruited armed forces personnel. Journal of Psychiatric Research 2022. [DOI: 10.1016/j.jpsychires.2022.02.022] [Reference Citation Analysis]
17 Salminen A. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev 2022;75:101573. [PMID: 35085834 DOI: 10.1016/j.arr.2022.101573] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
18 Mu C, Choudhary A, Mayengbam S, Barrett KT, Rho JM, Shearer J, Scantlebury MH. Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms. EBioMedicine 2022;76:103833. [PMID: 35090836 DOI: 10.1016/j.ebiom.2022.103833] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
19 Biswas P, Dai Y, Stuehr DJ. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through GAPDH- and Hsp90-dependent control of their heme levels. Free Radic Biol Med 2022:S0891-5849(22)00019-3. [PMID: 35051612 DOI: 10.1016/j.freeradbiomed.2022.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mondanelli G, Volpi C, Orabona C. Decoding the Complex Crossroad of Tryptophan Metabolic Pathways. Int J Mol Sci 2022;23:787. [PMID: 35054973 DOI: 10.3390/ijms23020787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Muneer A. Proteomic biomarkers for bipolar disorder. Biomarkers in Bipolar Disorders 2022. [DOI: 10.1016/b978-0-12-821398-8.00021-7] [Reference Citation Analysis]
22 Zhu X, Huang J, Huang S, Wen Y, Lan X, Wang X, Lu C, Wang Z, Fan N, Shang D. Combining Metabolomics and Interpretable Machine Learning to Reveal Plasma Metabolic Profiling and Biological Correlates of Alcohol-Dependent Inpatients: What About Tryptophan Metabolism Regulation? Front Mol Biosci 2021;8:760669. [PMID: 34859050 DOI: 10.3389/fmolb.2021.760669] [Reference Citation Analysis]
23 Boros FA, Vécsei L. Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson's disease. Expert Opin Ther Targets 2021;:1-12. [PMID: 34720020 DOI: 10.1080/14728222.2021.1999928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zakrocka I, Załuska W. Kynurenine pathway in kidney diseases. Pharmacol Rep 2021. [PMID: 34617264 DOI: 10.1007/s43440-021-00329-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
25 Büki A, Kekesi G, Horvath G, Vécsei L. A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia. Int J Mol Sci 2021;22:10016. [PMID: 34576179 DOI: 10.3390/ijms221810016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zhang P, Huang H, Gao X, Jiang J, Xi C, Wu L, Fu Y, Lai J, Hu S. Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review. Front Psychiatry 2021;12:677039. [PMID: 34381386 DOI: 10.3389/fpsyt.2021.677039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
27 Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines 2021;9:734. [PMID: 34202246 DOI: 10.3390/biomedicines9070734] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 59.0] [Reference Citation Analysis]
28 Alarcan H, Chaumond R, Emond P, Benz-De Bretagne I, Lefèvre A, Bakkouche SE, Veyrat-Durebex C, Vourc'h P, Andres C, Corcia P, Blasco H. Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis. Biomolecules 2021;11:691. [PMID: 34063031 DOI: 10.3390/biom11050691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Beggiato S, Zuccarini M, Cassano T, Borroto-Escuela DO, Di Iorio P, Schwarcz R, Fuxe K, Ferraro L. Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment? Front Pharmacol 2021;12:654426. [PMID: 33935767 DOI: 10.3389/fphar.2021.654426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Morales-Puerto N, Giménez-Gómez P, Pérez-Hernández M, Abuin-Martínez C, Gil de Biedma-Elduayen L, Vidal R, Gutiérrez-López MD, O'Shea E, Colado MI. Addiction and the kynurenine pathway: A new dancing couple? Pharmacol Ther 2021;223:107807. [PMID: 33476641 DOI: 10.1016/j.pharmthera.2021.107807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]